TEINT MULTIREGENRANT SPF 15
Natural health product licensed in Canada
- Licence holder
- Clarins Canada Inc.
- NPN or DIN-HM
- 80018016
- Status
- Inactive licence
- Licence date
- 23 April 2010
- Revision date
- Not provided
- Form
- Émulsion
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Dioxyde de titane Source : Dioxyde de titane | 2.5 % |
Non-medicinal ingredients
Avena sativa (oat) kernel extract, Phénoxyéthanol, Sorbitan Oleate, CI 77499, Diméthicone, Camellia Sinensis Leaf Extract, Dimethiconol, Acide poly(hydroxystéarique), Plantago major, Parfum, Stéarate de magnésium, CI 77491, Acide sorbique, Acacia senegal, CI 77019, Hydroxyéthyl urée, Cyclopentasiloxane, Polyglycerol-3 Diisostearate, Lapsana communis, Lauroyl lysine, acide alginique, Sulfate de magnésium, Eau, CI 77891, Dipoly(hydroxystéarate) de PEG-30, Silice, Dimethicone Crosspolymer-3, Butylène glycol, Benzoate de sodium, Hectorite de Distérdimonium, Isononyl isononanoate, CI 77492, Talc
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | Not specified |
Uses authorised in Canada
Protection modérée avec SPF 15.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Éviter tout contact avec les yeux. Cesser l'utilisation si une irritation de la peau se développe ou devient plus sévère. Si l'irritation persiste, consulter un praticien de soins de santé.
Source
Official Health Canada record, licence 80018016
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.